UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Onychomycosis: a review

Journal of the European Academy of Dermatology and Venereology, 2020-09, Vol.34 (9), p.1972-1990

2020

Volltextzugriff (PDF)

Lymphomatoid papulosis: an update and review

Journal of the European Academy of Dermatology and Venereology, 2020-01, Vol.34 (1), p.59-73

2020

Volltextzugriff (PDF)

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Clinical pharmacology and therapeutics, 2011-06, Vol.89 (6), p.896-901

2011

Volltextzugriff (PDF)

Tinea capitis in children: a systematic review of management

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2264-2274

2018

Volltextzugriff (PDF)

Efficacy of non‐surgical treatments for androgenetic alopecia: a systematic review and network meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.2112-2125

2018

Volltextzugriff (PDF)

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

British journal of dermatology (1951), 2014-06, Vol.170 (6), p.1341-1349

2014

Volltextzugriff (PDF)

Monotherapy for toenail onychomycosis: a systematic review and network meta‐analysis

British journal of dermatology (1951), 2020-02, Vol.182 (2), p.287-299

2020

Volltextzugriff (PDF)

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

British journal of dermatology (1951), 2007-11, Vol.157 (5), p.934-940

2007

Volltextzugriff (PDF)

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

British journal of dermatology (1951), 2016-08, Vol.175 (2), p.422-424

2016

Volltextzugriff (PDF)

Pemphigus and associated comorbidities: a cross-sectional study

Clinical and experimental dermatology, 2015-08, Vol.40 (6), p.593-599

2015

Volltextzugriff (PDF)

The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis

Journal of the European Academy of Dermatology and Venereology, 2020-03, Vol.34 (3), p.580-588

2020

Volltextzugriff (PDF)

Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.211-212

2019

Volltextzugriff (PDF)

A practical application of onychomycosis cure – combining patient, physician and regulatory body perspectives

Journal of the European Academy of Dermatology and Venereology, 2019-02, Vol.33 (2), p.281-287

2019

Volltextzugriff (PDF)

Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison

Journal of the European Academy of Dermatology and Venereology, 2019-06, Vol.33 (6), p.1107-1115

2019

Volltextzugriff (PDF)

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

British journal of dermatology (1951), 2006-07, Vol.155 (1), p.170-181

2006

Volltextzugriff (PDF)

Assessing finasteride‐associated sexual dysfunction using the FAERS database

Journal of the European Academy of Dermatology and Venereology, 2017-06, Vol.31 (6), p.1069-1075

2017

Volltextzugriff (PDF)

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

The Lancet (British edition), 2008-04, Vol.371 (9621), p.1337-1342

2008

Volltextzugriff (PDF)

Idiosyncratic drug reactions: the reactive metabolite syndromes

The Lancet (British edition), 2000-11, Vol.356 (9241), p.1587-1591

2000

Volltextzugriff (PDF)

Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice

British journal of dermatology (1951), 2014-09, Vol.171 (3), p.631-641

2014

Volltextzugriff (PDF)

'Is it safe?' Safety is a process, not a question

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.968-969

Shear, N.H.

2012

Volltextzugriff (PDF)

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis

Dermatology (Basel), 2008-01, Vol.217 (4), p.321-328

2008

Volltextzugriff (PDF)

Anticonvulsant hypersensitivity syndrome: Incidence, prevention and management

Drug safety, 1999-12, Vol.21 (6), p.489-501

1999

Volltextzugriff (PDF)

Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice

Quality of life research, 2016-08, Vol.25 (8), p.2031-2040

2016

Volltextzugriff (PDF)

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A review of 10 years' experience

Drug safety, 2002, Vol.25 (13), p.965-972

2002

Volltextzugriff (PDF)

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of the European Academy of Dermatology and Venereology, 2017-12, Vol.31 (12), p.e544-e547

2017

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(251)

Publikationsform

Artikel
(346)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Life Sciences & Biomedicine
(281)
Female
(183)
Male
(163)
Biological And Medical Sciences
(161)
Medical Sciences
(161)
Adult
(114)
Middle Aged
(112)
Dermatology
(103)
Pharmacology. Drug Treatments
(90)
Aged
(84)
Adolescent
(57)
Drug Toxicity And Drugs Side Effects Treatment
(51)
Child
(41)
Pharmacology & Pharmacy
(41)
General & Internal Medicine
(39)
Miscellaneous
(37)
Medicine, General & Internal
(34)
Treatment Outcome
(33)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Onychomycosis: a review

Lymphomatoid papulosis: an update and review

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

Tinea capitis in children: a systematic review of management

Efficacy of non‐surgical treatments for androgenetic alopecia: a systematic review and network meta‐analysis

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

Monotherapy for toenail onychomycosis: a systematic review and network meta‐analysis

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis

Pemphigus and associated comorbidities: a cross-sectional study

The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis

Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series

A practical application of onychomycosis cure – combining patient, physician and regulatory body perspectives

Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

Assessing finasteride‐associated sexual dysfunction using the FAERS database

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

Idiosyncratic drug reactions: the reactive metabolite syndromes

Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice

'Is it safe?' Safety is a process, not a question

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis

Anticonvulsant hypersensitivity syndrome: Incidence, prevention and management

Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A review of 10 years' experience

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Aktive Filter

Suchergebnisse filtern